Neurofilament light chain in blood and features of the multiple sclerosis course in patients with a history of traumatic brain injury
- 10 June 2025
- journal article
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 30 (2) , 27-31
Abstract
Multiple sclerosis (MS) is a chronic disease of the central nervous system with recurrent exacerbations, leading to irreversible disability, the development of which is based on axonal damage and demyelination. It is assumed that one of the candidate biomarkers of axonal damage may be a peptide component of the neuronal cytoskeleton — neurofilament light chain (NFL). Traumatic brain injury (TBI) before the onset of MS is associated with an increased rate of progression of neurological which may be due to increased astrogliosis as a late consequence of TBI. Objective: to evaluate the relationship between the level of NFL in the blood and the RP and exacerbation frequency MS in the presence/absence of TBI before the onset of MS.Material and methods. Caucasians born and living in the Altai region of Russia with relapsing-remitting MS in remission took part in a cross-sectional observational randomized study: 43 patients without a history of TBI and 43 patients with TBI before the onset of MS (MS duration 7.6 ± 6.6 and 5.9 ± 4.6 years, respectively, p = 0,113). Intracranial injury occurred 14.8 ± 7.8 years before the onset of MS and was documented as a concussion in 76% of patients.Results. The patient groups did not differ in the frequency of MS exacerbations, while RP was higher in the group with a history of TBI (p = 0.013). There were no intergroup differences in NFL levels (p = 0.613), as well as no correlations between NFL levels and RP (p = 0.499 and p = 0.776 groups with/without TBI, respectively) and the exacerbation frequency. No differences were found between subgroups of patients with different clinical forms of TBI in RP and NFL levels (H = 5,07; p = 0,679).Conclusion. The results of the study indicate a low probability of a connection between the level of NFL in the blood of patients with MS during the period of remission, both with the possible long-term consequences of a TBI received before the onset of MS, and with the course of MS.Keywords
This publication has 14 references indexed in Scilit:
- Multiple sclerosis: emerging epidemiological trends and redefining the clinical courseThe Lancet Regional Health - Europe, 2024
- Toward identifying key mechanisms of progression in multiple sclerosisTrends in Neurosciences, 2023
- Traumatic brain injury before the multiple sclerosis onset: a relationship with the progression of neurological disorders and pathobiochemical markers of the cerebrospinal fluidS.S. Korsakov Journal of Neurology and Psychiatry, 2023
- Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple SclerosisNeurologic Clinics, 2023
- The potential of serum neurofilament as biomarker for multiple sclerosisBrain, 2021
- Neurofilaments in progressive multiple sclerosis: a systematic reviewJournal of Neurology, 2020
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaThe Lancet Neurology, 2018
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Blood–brain barrier breakdown as a therapeutic target in traumatic brain injuryNature Reviews Neurology, 2010
- Rating neurologic impairment in multiple sclerosisNeurology, 1983